Patents by Inventor Zilong WANG

Zilong WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210343459
    Abstract: The present invention relates to an R-T-B sintered magnet and a preparation method thereof. The sintered magnet includes a grain boundary region T1, a shell layer region T2 and an R2Fe14B grain region T3; at 10 ?m to 60 ?m from a surface of the sintered magnet toward a center thereof, an area ratio of the shell layer region T2 to the R2Fe14B grain region T3 is 0.1 to 0.3, and a thickness of the shell layer region T2 is 0.5 ?m to 1.2 ?m; and an average coating percent of the shell layer region T2 on the R2Fe14B grain region T3 is 80% or more. In the present invention, by optimizing a preparation process and a microstructure of a traditional rare earth permanent magnet, diffusion efficiency of heavy rare earth in the magnet is improved, such that coercivity of the magnet is greatly improved, and manufacturing cost is reduced.
    Type: Application
    Filed: April 29, 2021
    Publication date: November 4, 2021
    Inventors: Yang LUO, Dunbo YU, Wei ZHU, Xinyuan BAI, Xiao LIN, Shengjie ZHU, Zilong WANG, Haijun PENG
  • Publication number: 20210268066
    Abstract: The present disclosure provides methods and kits for treating pain. More particularly, the present disclosure relates to methods of using PD-L1/PD-1-associated compounds to treat pain and/or bone destruction from bone cancer, and associated kits. The present disclosure also provides methods to assess the efficacy of compounds to suppress PD-1-associated nociceptive neuron activity.
    Type: Application
    Filed: May 11, 2021
    Publication date: September 2, 2021
    Applicant: Duke University
    Inventors: Ru-Rong Ji, Gang Chen, Zilong Wang, Changyu Jiang, Kaiyuan Wang
  • Patent number: 11007250
    Abstract: The present disclosure provides methods and kits for treating pain. More particularly, the present disclosure relates to methods of using PD-L1/PD-1-associated compounds to treat pain and/or bone destruction from bone cancer, and associated kits. The present disclosure also provides methods to assess the efficacy of compounds to suppress PD-1-associated nociceptive neuron activity.
    Type: Grant
    Filed: May 12, 2018
    Date of Patent: May 18, 2021
    Assignee: Duke University
    Inventors: Ru-Rong Ji, Gang Chen, Zilong Wang, Changyu Jiang, Kaiyuan Wang
  • Publication number: 20210129217
    Abstract: A method for preparing a rare earth anisotropic bonded magnetic powder, comprises the following steps: (1) preparing raw powder with RTBH as the main component, wherein, R is Nd or Pr/Nd, and T is a transition metal containing Fe; (2) adding La/Ce hydride and copper powder to the raw powder to form a mixture; (3) subjecting the mixture to atmosphere diffusion heat treatment to give the rare earth anisotropic bonded magnetic powder. The invention selects high-abundance rare earth elements La, Ce to replace Dy, Tb, Nd, Pr and other medium and heavy rare earth elements, which can achieve the same coercivity improvement effect while also significantly reducing the cost, thereby achieving efficient application of low-cost and high-abundance rare earths.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 6, 2021
    Inventors: Yang LUO, Zilong WANG, Yuanfei Yang, Zhou HU, Dunbo Yu, Jiajun XIE, Yifan LIAO, Zhongkai WANG
  • Publication number: 20210130939
    Abstract: The invention discloses an anisotropic bonded magnetic powder and a preparation method thereof. The anisotropic bonded magnetic powder has a general formula of R1R2TB, wherein R1 is a rare earth element containing Nd or PrNd, R2 is one or two of La and Ce, T is a transitional element, and B is boron. The preparation method includes the steps of smelting the master alloy to prepare ingot(s), preparing a rare earth hydride of formula R1TBHX, preparing a hydride diffusion source of formula R1R2THX, mixing, heat treating, and high-vacuum dehydrogenating, to obtain the anisotropic bonded magnetic powder. The invention uses La and Ce hydrides as the diffusion source, can save cost, remove hydrogen from the diffusion source at a lower dehydrogenation temperature, avoid crystal grain growth at a high temperature, and ensure the quality of the product.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 6, 2021
    Inventors: Yang Luo, Zhongkai Wang, Yuanfei Yang, Zilong Wang, Dunbo Yu, Yifan Liao, Jiajun Xie, Zhou Hu
  • Publication number: 20210134499
    Abstract: The invention discloses a composite rare earth anisotropic bonded magnet and a preparation method thereof. The composite rare earth anisotropic bonded magnet comprises a Nd—Fe—B magnetic powder, a Sm—Fe—N magnetic powder, a binder and an inorganic nano-dispersant. The preparation method comprises steps of preparing a Nd—Fe—B magnetic powder by a HDDR method, preparing a Sm—Fe—N magnetic powder by a powder metallurgy method, mixing the Nd—Fe—B magnetic powder, the Sm—Fe—N magnetic powder, the binder and the inorganic nano-dispersant at a specific ratio to finally obtain the composite rare earth anisotropic bonded magnet. The invention, by adding an inorganic nano-dispersant, enables the full dispersion of the fine Sm—Fe—N powder during the mixing process of the binder, the Nd—Fe—B magnetic powder and the Sm—Fe—N powder, and thus makes the fine Sm—Fe—N powder and the binder evenly coated on the surface of the anisotropic Nd—Fe—B magnetic powder.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 6, 2021
    Inventors: Yang Luo, Zhongkai Wang, Yuanfei Yang, Zilong Wang, Dunbo Yu, Yifan Liao, Jiajun Xie, Zhou Hu
  • Publication number: 20200263280
    Abstract: The present disclosure discloses an yttrium (Y)-added rare-earth permanent magnetic material and a preparation method thereof. A chemical formula of the material expressed in atomic percentage is (YxRE1-x)aFebalMbNc, wherein 0.05?x?0.4, 7?a?13, 0?b?3, 5?c?20, and the balance is Fe, namely, bal=100-a-b-c; RE represents a rare-earth element Sm, or a combination of the rare-earth element Sm and any one or more elements of Zr, Nd and Pr; M represents Co and/or Nb; and N represents nitrogen. In the preparation method, the rare-earth element Y is utilized to replace the element Sm of a samarium-iron-nitrogen material. By regulating a ratio of the element Sm to the element Y, viscosity of an alloy liquid can be reduced, and an amorphous forming ability of the material is enhanced.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 20, 2020
    Inventors: Yang LUO, Xiao LIN, Guiyong WU, Jiajun XIE, Zilong WANG, Wenlong YAN, Zhongkai WANG, Dunbo YU
  • Publication number: 20200078443
    Abstract: The present disclosure provides methods and kits for treating pain. More particularly, the present disclosure relates to methods of using PD-L1/PD-1-associated compounds to treat pain and/or bone destruction from bone cancer, and associated kits. The present disclosure also provides methods to assess the efficacy of compounds to suppress PD-1-associated nociceptive neuron activity.
    Type: Application
    Filed: May 12, 2018
    Publication date: March 12, 2020
    Inventors: Ru-Rong Ji, Gang Chen, Zilong Wang, Changyu Jiang, Kaiyuan Wang
  • Publication number: 20190375790
    Abstract: Provided are nine multi-target polypeptides of an opioid and a neuropeptide FF receptor, where an amino acid is replaced on the basis of opioid peptide biphalin- and NPFF-based chimeric peptide BN-9, and acquired are the multi-target polypeptides capable of concurrently activating various opioid and NPFF system receptors.
    Type: Application
    Filed: April 13, 2017
    Publication date: December 12, 2019
    Inventors: Rui WANG, Quan FANG, Zilong WANG, Biao XU